SG Americas Securities LLC Purchases New Holdings in Balchem Co. (BCPC)

SG Americas Securities LLC purchased a new position in shares of Balchem Co. (NASDAQ:BCPC) in the first quarter, according to its most recent filing with the SEC. The firm purchased 2,602 shares of the basic materials company’s stock, valued at approximately $213,000.

A number of other institutional investors have also modified their holdings of BCPC. Schwab Charles Investment Management Inc. grew its holdings in Balchem by 10.9% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 170,119 shares of the basic materials company’s stock worth $13,712,000 after acquiring an additional 16,782 shares during the period. Comerica Bank boosted its position in shares of Balchem by 10.3% during the 4th quarter. Comerica Bank now owns 42,426 shares of the basic materials company’s stock worth $3,399,000 after purchasing an additional 3,964 shares in the last quarter. Aperio Group LLC boosted its position in shares of Balchem by 10.3% during the 4th quarter. Aperio Group LLC now owns 10,482 shares of the basic materials company’s stock worth $845,000 after purchasing an additional 975 shares in the last quarter. SeaCrest Wealth Management LLC bought a new position in shares of Balchem during the 4th quarter worth about $113,000. Finally, Teacher Retirement System of Texas boosted its position in shares of Balchem by 317.4% during the 4th quarter. Teacher Retirement System of Texas now owns 10,999 shares of the basic materials company’s stock worth $887,000 after purchasing an additional 8,364 shares in the last quarter. Hedge funds and other institutional investors own 87.25% of the company’s stock.

A number of research firms have recently issued reports on BCPC. BidaskClub raised shares of Balchem from a “buy” rating to a “strong-buy” rating in a research report on Friday, May 25th. Vertical Group cut shares of Balchem from a “buy” rating to a “hold” rating in a research report on Monday, May 7th. They noted that the move was a valuation call. Finally, Pivotal Research raised shares of Balchem from a “sell” rating to a “hold” rating and set a $85.00 price objective on the stock in a research report on Monday, May 7th.

Balchem opened at $99.21 on Monday, Marketbeat Ratings reports. The stock has a market cap of $3.19 billion, a PE ratio of 36.61 and a beta of 0.93. The company has a current ratio of 2.16, a quick ratio of 1.48 and a debt-to-equity ratio of 0.28. Balchem Co. has a 1 year low of $70.23 and a 1 year high of $99.93.

Balchem (NASDAQ:BCPC) last released its quarterly earnings data on Friday, May 4th. The basic materials company reported $0.76 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.70 by $0.06. The company had revenue of $161.41 million for the quarter. Balchem had a net margin of 15.18% and a return on equity of 14.50%.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply